Is GE HealthCare (GEHC) a risky stock?
As of July 21, 2026, Clavix grades GE HealthCare (GEHC) B for risk, a composite score of 73 out of 100 on an A+ to F scale, which puts GEHC in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind GEHC's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how GEHC scores on each, as of July 21, 2026.
What's moving GEHC's risk right now
Company-specific signals Clavix flags behind GEHC's current grade, drawn from recent news and filings as of July 21, 2026.
Price structure and relative strength suggest accumulation, which often precedes fundamental re-rating catalysts.
The long-term deal provides GEHC with a predictable, multi-year revenue stream and deepens its footprint in the U.S. hospital market, which investors rewarded with a notable stock…
This multi-year, large-value contract strengthens GE HealthCare's installed base and recurring revenue visibility in its core U.S. hospital market, with $50M/year average revenue…
What a B grade means
On the Clavix A+ to F scale, GEHC's composite of 73 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell GEHC or any security. Grades are risk indicators, not predictions of return. Data may be delayed.